{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T23:55:56Z","timestamp":1774655756010,"version":"3.50.1"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","funder":[{"DOI":"10.13039\/100014008","name":"Ovarian Cancer Research Alliance","doi-asserted-by":"crossref","award":["Collaborative Award"],"award-info":[{"award-number":["Collaborative Award"]}],"id":[{"id":"10.13039\/100014008","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100016229","name":"Basic Research Laboratory","doi-asserted-by":"crossref","award":["R37CA261987"],"award-info":[{"award-number":["R37CA261987"]}],"id":[{"id":"10.13039\/100016229","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100014042","name":"DOD Peer Reviewed Cancer Research Program","doi-asserted-by":"crossref","award":["OC170228, OC200302, OC200225"],"award-info":[{"award-number":["OC170228, OC200302, OC200225"]}],"id":[{"id":"10.13039\/100014042","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"crossref","award":["RSG-19-129-01-DDC"],"award-info":[{"award-number":["RSG-19-129-01-DDC"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To determine biomarkers other than CA 125 that could be used in identifying early-stage ovarian cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DATA SOURCES:<\/jats:title>\n            <jats:p>Ovid MEDLINE ALL, EMBASE, Web of Science Core Collection, ScienceDirect, Clinicaltrials.gov, and CAB Direct were searched for English-language studies between January 2008 and April 2023 for the concepts of high-grade serous ovarian cancer, testing, and prevention or early diagnosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS OF STUDY SELECTION:<\/jats:title>\n            <jats:p>The 5,523 related articles were uploaded to Covidence. Screening by two independent reviewers of the article abstracts led to the identification of 245 peer-reviewed primary research articles for full-text review. Full-text review by those reviewers led to the identification of 131 peer-reviewed primary research articles used for this review.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>TABULATION, INTEGRATION, AND RESULTS<\/jats:title>\n            <jats:p>Of 131 studies, only 55 reported sensitivity, specificity, or area under the curve (AUC), with 36 of the studies reporting at least one biomarker with a specificity of 80% or greater specificity or 0.9 or greater AUC.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>These findings suggest that although many types of biomarkers are being tested in ovarian cancer, most have similar or worse detection rates compared with CA 125 and have the same limitations of poor detection rates in early-stage disease. However, 27.5% of articles (36\/131) reported biomarkers with better sensitivity and an AUC greater than 0.9 compared with CA 125 alone and deserve further exploration.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aog.0000000000005496","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T22:00:48Z","timestamp":1704405648000},"page":"e63-e77","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Early Ovarian Cancer Detection in the Age of Fallopian Tube Precursors"],"prefix":"10.1097","volume":"143","author":[{"given":"Ashley","family":"Greenwood","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth R.","family":"Woodruff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cam","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christi","family":"Piper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Clauset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsay W.","family":"Brubaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kian","family":"Behbakht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin G.","family":"Bitler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,1,4]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J Pathol"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GCO.0b013e328011a21f","article-title":"The distal fallopian tube: a new model for pelvic serous carcinogenesis","volume":"19","author":"Crum","year":"2007","journal-title":"Curr Opin Obstet Gynecol"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1001\/jama.291.22.2705","article-title":"Frequency of symptoms of ovarian cancer in women presenting to primary care clinics","volume":"291","author":"Goff","year":"2004","journal-title":"JAMA"},{"issue":"suppl 23","key":"R4-20250502","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1002\/cncr.29049","article-title":"The Surveillance, Epidemiology, and End Results (SEER) program of the National Cancer Institute","volume":"120","author":"Cronin","year":"2014","journal-title":"Cancer"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/S0140-6736(21)00731-5","article-title":"Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial","volume":"397","author":"Menon","year":"2021","journal-title":"Lancet"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1055\/a-1239-3958","article-title":"Biological impact of unilateral oophorectomy: does the number of ovaries really matter?","volume":"81","author":"Gasparri","year":"2021","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"e24414","DOI":"10.2196\/24414","article-title":"Long-term morbidity and health after early menopause due to oophorectomy in women at increased risk of ovarian cancer: protocol for a nationwide cross-sectional study with prospective follow-up (HARMOny study)","volume":"10","author":"Terra","year":"2021","journal-title":"JMIR Res Protoc"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13048-019-0503-7","article-title":"Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review","volume":"12","author":"Dochez","year":"2019","journal-title":"J Ovarian Res"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1097\/AOG.0000000000001768","article-title":"Evaluation and management of adnexal masses. Practice Bulletin No. 174. American College of Obstetricians and Gynecologists","volume":"128","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R10-20250502","first-page":"511","article-title":"Predictive value of CA 125 in detection of ovarian cancer in pre- and postmenopausal patients","volume":"81","author":"Grzybowski","year":"2010","journal-title":"Ginekol Pol"},{"key":"R11-20250502","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.1007\/s13277-014-1811-6","article-title":"Diagnostic accuracy of serum HE4, CA125 and ROMA in patients with ovarian cancer: a meta-analysis","volume":"35","author":"Wang","year":"2014","journal-title":"Tumour Biol"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1038\/s41598-020-59009-z","article-title":"Pre-operative sera interleukin-6 in the diagnosis of high-grade serous ovarian cancer","volume":"10","author":"Kampan","year":"2020","journal-title":"Sci Rep"},{"key":"R13-20250502","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ygyno.2008.08.031","article-title":"A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass","volume":"112","author":"Moore","year":"2009","journal-title":"Gynecol Oncol"},{"key":"R14-20250502","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/IGC.0000000000000181","article-title":"Prognostic value of serum HE4 levels and risk of ovarian malignancy algorithm scores at the time of ovarian cancer diagnosis","volume":"24","author":"Kaijser","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"R15-20250502","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3892\/mco.2022.2551","article-title":"Diagnostic value of risk of malignancy index in the clinical evaluation of ovarian mass","volume":"17","author":"Huwidi","year":"2022","journal-title":"Mol Clin Oncol"},{"key":"R16-20250502","first-page":"627","article-title":"Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation","volume":"4","author":"Hajian-Tilaki","year":"2013","journal-title":"Caspian J Intern Med"},{"key":"R17-20250502","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3233\/CBM-182120","article-title":"Sub-terahertz vibrational spectroscopy of ovarian cancer and normal control tissue for molecular diagnostic technology","volume":"24","author":"Globus","year":"2019","journal-title":"Cancer Biomark"},{"key":"R18-20250502","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ygyno.2020.11.016","article-title":"Genetically predicted circulating protein biomarkers and ovarian cancer risk","volume":"160","author":"Considine","year":"2021","journal-title":"Gynecol Oncol"},{"key":"R19-20250502","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00404-012-2279-5","article-title":"Adenosine deaminase activity in patients with ovarian neoplasms","volume":"286","author":"Urunsak","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"R20-20250502","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1021\/acs.jproteome.2c00218","article-title":"Novel diagnostic biomarkers for high-grade serous ovarian cancer uncovered by data-independent acquisition mass spectrometry","volume":"21","author":"Huh","year":"2022","journal-title":"J Proteome Res"},{"key":"R21-20250502","doi-asserted-by":"crossref","first-page":"e0164230","DOI":"10.1371\/journal.pone.0164230","article-title":"Blood plasma-derived anti-glycan antibodies to sialylated and sulfated glycans identify ovarian cancer patients","volume":"11","author":"Pochechueva","year":"2016","journal-title":"PLoS One"},{"key":"R22-20250502","doi-asserted-by":"crossref","first-page":"6310","DOI":"10.1158\/1078-0432.CCR-20-0270","article-title":"Methylomic landscapes of ovarian cancer precursor lesions","volume":"26","author":"Pisanic","year":"2020","journal-title":"Clin Cancer Res"},{"key":"R23-20250502","doi-asserted-by":"crossref","first-page":"6536","DOI":"10.1158\/1078-0432.CCR-18-1199","article-title":"Methylomic analysis of ovarian cancers identifies tumor-specific alterations readily detectable in early precursor lesions","volume":"24","author":"Pisanic","year":"2018","journal-title":"Clin Cancer Res"},{"key":"R24-20250502","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.7150\/jca.30231","article-title":"Serum exosomal miRNA-145 and miRNA-200c as promising biomarkers for preoperative diagnosis of ovarian carcinomas","volume":"10","author":"Kim","year":"2019","journal-title":"J Cancer"},{"key":"R25-20250502","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.canlet.2016.12.017","article-title":"Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: a validation across two independent cohorts","volume":"388","author":"Todeschini","year":"2017","journal-title":"Cancer Lett"},{"key":"R26-20250502","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","year":"2011","journal-title":"Nature"},{"key":"R27-20250502","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nature14410","article-title":"Whole-genome characterization of chemoresistant ovarian cancer","volume":"521","author":"Patch","year":"2015","journal-title":"Nature"},{"key":"R28-20250502","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1097\/AOG.0000000000000484","article-title":"Detection of somatic TP53 mutations in tampons of patients with high-grade serous ovarian cancer","volume":"124","author":"Erickson","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R29-20250502","doi-asserted-by":"crossref","first-page":"14814","DOI":"10.3390\/ijms232314814","article-title":"Using genomic variation to distinguish ovarian high-grade serous carcinoma from benign fallopian tubes","volume":"23","author":"Gonzalez-Bosquet","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R30-20250502","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1158\/1078-0432.CCR-16-1078","article-title":"Chromosomal instability in cell-free DNA as a highly specific biomarker for detection of ovarian cancer in women with adnexal masses","volume":"23","author":"Vanderstichele","year":"2017","journal-title":"Clin Cancer Res"},{"key":"R31-20250502","article-title":"Single-cell transcriptomics identifies gene expression networks driving differentiation and tumorigenesis in the human fallopian tube","volume":"35","author":"Dinh","year":"2021"},{"key":"R32-20250502","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1158\/1541-7786.MCR-19-1057","article-title":"Targeting fatty acid oxidation to promote anoikis and inhibit ovarian cancer progression","volume":"18","author":"Sawyer","year":"2020","journal-title":"Mol Cancer Res"},{"key":"R33-20250502","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm.2492","article-title":"Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth","volume":"17","author":"Nieman","year":"2011","journal-title":"Nat Med"},{"key":"R34-20250502","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1038\/s41388-017-0093-z","article-title":"Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis","volume":"37","author":"Ladanyi","year":"2018","journal-title":"Oncogene"},{"key":"R35-20250502","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/s41416-018-0270-z","article-title":"Ovarian tumours of different histologic type and clinical stage induce similar changes in lipid metabolism","volume":"119","author":"Niemi","year":"2018","journal-title":"Br J Cancer"},{"key":"R36-20250502","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1200\/JCO.2015.61.3083","article-title":"Lavage of the uterine cavity for molecular detection of m\u00fcllerian duct carcinomas: a proof-of-concept study","volume":"33","author":"Maritschnegg","year":"2015","journal-title":"J Clin Oncol"},{"key":"R37-20250502","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1097\/IGC.0000000000001361","article-title":"Uterine and tubal lavage for earlier cancer detection using an innovative catheter: a feasibility and safety study","volume":"28","author":"Maritschnegg","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"R38-20250502","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1074\/mcp.RA119.001362","article-title":"Microvesicle proteomic profiling of uterine liquid biopsy for ovarian cancer early detection","volume":"18","author":"Barnabas","year":"2019","journal-title":"Mol Cell Proteomics"},{"key":"R39-20250502","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/IGC.0000000000001267","article-title":"The clearance of serum human epididymis protein 4 following primary cytoreductive surgery for ovarian carcinoma","volume":"28","author":"Thompson","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"R40-20250502","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.3802\/jgo.2017.28.e7","article-title":"Perioperative changes in serum CA125 levels: a prognostic factor for disease-specific survival in patients with ovarian cancer","volume":"28","author":"Zwakman","year":"2017","journal-title":"J Gynecol Oncol"},{"key":"R41-20250502","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1200\/JCO.2014.59.4945","article-title":"Risk algorithm using serial biomarker measurements doubles the number of screen-detected cancers compared with a single-threshold rule in the United Kingdom collaborative trial of ovarian cancer screening","volume":"33","author":"Menon","year":"2015","journal-title":"J Clin Oncol"},{"key":"R42-20250502","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10552-020-01384-z","article-title":"Racial\/ethnic differences in average CA125 and CA15.3 values and its correlates among postmenopausal women in the USA","volume":"32","author":"Sasamoto","year":"2021","journal-title":"Cancer Causes Control"},{"key":"R43-20250502","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3390\/diagnostics10020102","article-title":"Serous tubal intraepithelial carcinoma: a concise review for the practicing pathologist and clinician","volume":"10","author":"Bachert","year":"2020","journal-title":"Diagnostics"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000005496","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:02:13Z","timestamp":1746230533000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000005496"}},"subtitle":["A Systematic Review"],"short-title":[],"issued":{"date-parts":[[2024,1,4]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000005496","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,4]]},"assertion":[{"value":"2023-09-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}